Bristol-Myers Squibb: Pharma Giant Still Undervalued And Printing Cash Despite Patent Cliff [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
Despite an estimated 60% revenue facing loss of exclusivity risks, BMY's growth portfolio delivered 18% growth in Q3 and now exceeds 50% of business mix. Robust free cash flow margins (30%) and a 4.7% yield provide BMY investors with attractive compensation while awaiting pipeline catalysts. Buy rating firmly maintained, with BMY stock still visibly undervalued (8.8x forward P/E) and still offers 20% potential upside, through the $65 resistance zone. JHVEPhoto/iStock Editorial via Getty Images Bristol-Myers Squibb: Finally Overcame The Pessimism Healthcare stocks are getting a much-needed revival finally. And that has also boosted stocks like Bristol-Myers Squibb Company ( BMY ), as the market finally understands that the previous More on my IG service A Growth Investing Service To Help You Outperform I'm a firm believer in growth and tech plays as a core component of our portfolio. Our service has made several top and bottom calls, helping our subscribers to outper
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol-Myers Squibb Surges Into Year-End: Why BMY Still Looks Undervalued [Seeking Alpha]Seeking Alpha
- Bristol-Myers Squibb: Still Undervalued And Generating 4.65% Dividend Yield [Seeking Alpha]Seeking Alpha
- Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
- Bristol-Myers Squibb: Recent Gains Impress, But Tricky Tests Lie Ahead [Seeking Alpha]Seeking Alpha
- FDA Approves Bristol-Myers Squibb's Breyanzi as First-Ever CAR T Therapy for Rare Marginal Zone Lymphoma [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 10/31/25 - Beat
BMY
Sec Filings
- 11/18/25 - Form 8-K
- 11/12/25 - Form CERT
- 11/10/25 - Form 8-A12B
- BMY's page on the SEC website